While they sometimes have opposing interests, payers and drug companies can work together so that patients have better access to new, innovative medications, according to a Health Affairs Blog post.
Democratic presidential candidate Hillary Clinton introduced a policy plan Tuesday that addresses the cost of prescription drugs and builds on the Affordable Care Act.
In order to curb the rising costs of prescription drugs, it's imperative to transition the payment system to charge for value as opposed to volume, according to a recent report from the Center for American Progress.
Americans have deeply conflicted views about the pharmaceutical sector, grateful that the prescription medications help improve their health, but generally skeptical as to the reasons behind their cost increases, according to a new tracking poll by the Henry J. Kaiser Family Foundation.
Patient advocate groups, supported by drug companies, are hoping to put a damper on insurers' efforts to lower rising drug costs, reported Bloomberg. A campaign called Cap the Copay, which is financed by Pfizer and other pharmaceutical companies, is pushing for state laws that require insurers cover most drug costs by limiting the amount they can charge members each month.
Medicare Part D fraud and spending trends made news last week in a trio of articles focusing on whistleblowing targets and program cost containment.
America's Health Insurance Plans has called out the drug industry for the soaring costs of new specialty medications, saying such expensive pricing is unsustainable and takes unfair advantage of health insurers
President Obama's budget proposal involves some $360 billion in reductions to the Medicare and Medicaid budgets over the next decade, reported The Washington Post. The reductions include cuts in